Erick Gamelin

ACRV

Erick Gamelin serves as Chief Development Officer at Acrivon Therapeutics, Inc. Common Stock (ACRV). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

10 trades

$23.3K

Net Position

Net Seller

$23.3K

Companies Traded

ACRV

Active Period

Nov 2023 – Feb 2026

10 total trades

Most Recent

Sell ACRV

Feb 14, 2026 · $767.73

Erick Gamelin's Insider Trading at Acrivon Therapeutics, Inc. Common Stock (ACRV)

Buys

0 · $0.00

Sells

10 · $23.3K

Total Shares Bought

Total Shares Sold

5,218

ACRV Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Feb 14, 2026	Sell	471	$1.63	$767.73
Nov 14, 2025	Sell	403	$2.24	$902.72
Aug 14, 2025	Sell	403	$1.39	$560.17
May 14, 2025	Sell	403	$1.14	$459.42
Feb 14, 2025	Sell	469	$5.42	$2.5K
Nov 14, 2024	Sell	402	$7.92	$3.2K
Aug 14, 2024	Sell	402	$7.02	$2.8K
May 14, 2024	Sell	402	$8.36	$3.4K
Feb 14, 2024	Sell	468	$3.40	$1.6K
Nov 14, 2023	Sell	1,395	$5.08	$7.1K